SURYAPHARM

Surya Pharmaceutical Limited has informed the Exchange that M/s. Bansal Mittal & Co., Chartered Accountants, the Statutory Auditiors of the company has submitted their resignation from the office of the Statutory Auditors of the company vide their letter dated August 03, 2006 due to their personal reasons. The Board of Directors, in their meeting held on August 05, 2006 has accepted the resignation and has proposed to appoint M/s. AAD & Associates SCO No. 371 373, IInd Floor, Sector 34-A, Chandigarh, Chartered Accountants, as the Statutory Auditors of the company.

Surya Pharmaceutical Limited has informed the Exchange that in Extra Ordinary General Meeting of the Company held on August 31, 2006, the shareholders have approved the appointment of M/s. AAD & Associates SCO No. 371-373, IInd Floor, Sector 34-A, Chandigarh, Chartered Accountants to fill up the vacancy arisen out of resignation of the earlier Statutory Auditors.

Surya Pharmaceutical Limited has informed the Exchange that pursuant to the option exercised by investors regarding conversion of Share Warrants, the Board of Directors of the Company, in their meeting held on August 05, 2006 have allotted 13,91,250 fully paid equity shares on preferential basis as per the following details:- (1) Name of Investor - M/s. Dynamic Finvest Services P. Limited - No. of Equity Shares - 4,000; (2) Name of Investor - Mrs. Alka Goyal - No. of Equity Shares - 41,200; (3) Name of Investor - Mr. Rajeev Goyal - No. of Equity Shares - 2,00,000. (4) M/s. Creative Capital Ser

Surya Pharmaceutical Limited has informed the Exchange that pursuant to the option exercised by investor regarding conversion of warrants, the Board of Directors of the Company, in their meeting held on July 29, 2006 have allotted 15,98,750 fully paid equity shares on preferential basis as per the following details:- (1) Name of Investor - M/s. Creative Capital Services Limited - No. of Equity Shares -3,950; (2) Name of Investor - Mrs. Alka Goyal - No. of Equity Shares -1,58,800; (3) Name of Investor - M/s. Dynamic Finvest Services P. Limited - No. of Equity Shares - 14,36,000. The total share

Surya Pharmaceutical Limited has informed the Exchange that pursuant to the option exercised by investor regarding conversion of warrants, the Board of Directors of the Company, in their meeting held on April 29, 2006 have allotted 4,00,000 fully paid equity shares on preferential basis as per the following details:- (1) Name of Investor - M/s. Creative Capital Services Limited. No. of Equity Shares - 4,00,000. The total share capital after conversion stands at Rs. 11,47,83,380/- dividend into 1,14,78,338 fully paid equity shares Rs. 10.00 each.

Surya Pharmaceutical Limited has informed the Exchange that the FCCB Issue Committee, in its meeting held on April 07, 2006, has revised the convertibility of Foreign Currency Convertible Bonds issued by the company, in terms of Reset Clause 7.2.4 of the Trust Deed Agreement, whereby effective April 07, 2006 onwards, the company shall allot 287.7865 fully paid equity shares for each FCCB of USD 1000.00. The Authorised Capital of the company is sufficient to accommodate the marginal increased in Equity Shares to be issued upon Conversion.

Surya Pharmaceutical Limited has informed the Exchange that M/s. Dynamic Finvest Services P. Ltd. has acquired 3,75,000 shares of Surya Pharmaceuticals Limited as follows :- (1) 1,25,000 shares on March 24, 2006; (2) 1,50,000 shares on March 27, 2006; (3) 1,00,000 shares on March 28, 2006. The mode of acquisition is through Open Market and the shareholding of M/s. Dynamic Finvest Services P. Ltd. after the said acquisition is 6,35,000 shares agregating to 5.73% of the paid up capital of Surya Pharmaceuticals Limited.

Surya Pharmaceutical Limited has informed the Exchange that Mrs. Alka Goyal (Acquirer) along with PACs: Rajeev Goyal; Sohail Goyal; Saanya Goyal; Rajeev & Sons (HUF) and Anil Arya has acquired 5,50,000 shares aggregating to 4.96% of the total paid up capital of Surya Pharmaceutical Limited as follows :- (1) On February 23, 2006 acquired 1,00,000 shares. (2) On February 24, 2006 acquired 1,00,000 shares. (3) On March 07, 2006 acquired 1,25,000 shares. (4) On March 08, 2006 acquired 1,75,000 shares. (5) On March 10, 2006 acquired 50,000 shares. The mode of acquisition is through Open Market and

Surya Pharmaceutical Limited has submitted to the Exchange a copy of the proceedings of the EGM held on February 25, 2006. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Surya Pharmaceutical Limited has informed the Exchange that the Board of Directors at their meeting held on January 28, 2006 have interalia approved the following :-(i) subject to the approval of the shareholders, the Company has resolved to increase the authorised capital of the company from Rs.20.00 Crores, divided into 2,00,00,000 Equity shares of Rs.10.00 each, to Rs.26.00 Crores, divided into 2,60,00,000 Equity Shares of Rs.10.00 each. (ii) Subject to the approval of the shareholders the Company has resolved to amend Memorandum of Association and Articles of Association to give effect to

Surya Pharmaceutical Limited has informed the Exchange that 12000 Foreign Currency Convertible Bonds (FCCBs) allotted by the company on September 29, 2005 @ US$ 1000 each convertible into equity shares at a price of Rs. 170/- per share, subject to other terms and conditions of issue, to DE Shaw Vallance International Inc, Tortola, British Virgin Islands have been listed with Luxembourg Stock Exchange with effect from October 12, 2005. The Company has received the entire proceeds of USD 12 millions in respect of the FCCBs Issue and the total process has been completed.

Surya Pharmaceutical Limited has submitted to the Exchange a copy of proceedings of the AGM held on September 30, 2005. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Surya Pharmaceutical Limited has informed the Exchange as follows: 1) the FCCB issue of the Company closed at 1.30 p.m. (Indian time) on September 29, 2005 and has been fully subscribed. 2) The Board of Directors in their meeting held on September 29, 2005, has allotted the entire 12000 FCCBs (including greenshoe option of 2000 FCCBs) @ US$ 1000 each convertible into equity shares at a price of Rs.170/- per share, subject to other terms and conditions of issue, to DE Shaw Vallance International Inc, Tortola, British Virgin Islands.

Surya Pharmaceutical Limited has informed the Exchange that the proposed FCCBs Issue of the Company for issue of 12000 Foreign Currency Convertible Bonds (including greenshoe option of 2000 Bonds) in the first trench at a price of USD 1000 each shall open with the start of working hours on September 26, 2005 and shall close with the closing of business hours on September 29, 2005.

Surya Pharmaceutical Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed on September 30, 2005 for the purpose of AGM of the company to be held on September 30, 2005.

Surya Pharmaceutical Limited has submitted to the Exchange a copy of Proceedings of EGM of the members of the Company held on August 08, 2005. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Surya Pharmaceutical Limited has informed the Exchange that pursuant to the option exercised by investors regarding conversion of warrants the Board of Directors of the Company, in their meeting held on July 30, 2005 have allotted 4,00,000 fully paid equity shares on preferential basis per the following details: 1)Dynamic Finvest Services (P) Ltd., - No. of Equity Shares 50,000.2) M/s Creative Capital Services Limited - No of Equity Shares 3,50,000 .The total share Capital after conversion stands at Rs.11,07,83,380/- divided into 1,10,78,338 fully paid equity shares of Rs 10.00 each. These war

Surya Pharmaceutical Limited has informed the Exchange that an EGM of the members of the Company will be held on August 08, 2005. The details of the EGM notice shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Surya Pharmaceutical Limited has informed the Exchange that the Board of Directors in their meeting held on July 05, 2005 have taken the following decisions: 1) Subject to the approval of the shareholders, the company has resolved to increase the authorised capital of the company from Rs.15.00 Crores, divided into 1,50,00,000 Equity Shares of Rs.10.00 each, to Rs.20.00 Crores divided into 2,00,00,000 Equity Shares of Rs.10.00 each. 2) Subject to the approval of the shareholders, the Company has resolved to amend Memorandum of Association and Article of Association to give effect to the increas

Surya Pharmaceutical Limited has informed the Exchange that following persons have resigned from the directorship of the company: 1. Mr. Uday Shantaram Karnik, Director-Marketing. 2. Mr. S.M. Singla, Director-Finance.

Surya Pharmaceutical Limited has informed the Exchange that pursuant to the option exercised by M/s Dynamic Finvest Services (P) Ltd. regarding conversion of warrants the Board of Directors of the Company, in their meeting held on March 29, 2005 have allotted 2,10,000 fully equity shares on preferential basis per the following details: Dynamic Finvest Services (P) Ltd., - No. of Equity Shares 2,10,000 - Total Capital after increase 1,06,78,338 - % holding 1.97. These warrants were allotted through preferential allotment on February 07, 2005 and are subjected to lock-in period of One year i.e

Surya Pharmaceutical Limited has informed the Exchange that the BODs,in their meeting held on February 07,2005 have allotted 40,00,000 Zero Coupon Convertible Share warrants as per the following details: [1] Sh.Rajeev Goyal is allotted 2,00,000 warrants (Distinctive Nos.00001 to 200000). [2] Smt.Alka Goyal is allotted 2,00,000 warrants (Distinctive Nos.200001 to 400000). [3] Dynamic Finvest Services Pvt.Ltd. is allotted 17,00,000 warrants (Distinctive Nos.400001 to 2100000). [4] Creative Capital Services Ltd. is allotted 19,00,000 warrants ( Distinctive Nos.2100001 to 4000000). The above war

Surya Pharmaceutical Limited has informed the Exchange that all items as mentioned in the notice of the EGM have been approved in the EGM of the company held on January 24,2005.

Surya Pharmaceutical Limited has informed the Exchange that the company has approved a proposal to set up a plant for manufacture of Sterile Bulk Drugs. In this regard, the company has filed IEM on January 10,2005 with Secretariat of Industrial Approvals(SIA),Department of Industrial Policy & Promotion, Ministry of Industry for setting up this project in J & K at Jammu at an approx. outlay of Rs. 77 crores.

Clarification of News : The press had reports that Surya Pharmaceutical Limited may do a private equity placement to a leading foreign institutional investor at around Rs.250 per share. The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Surya Pharmaceutical Limited has vide its letter inter-alia stated, "As on date we do not have any plan of placing equity with any Foreign Institutional Investor on preferential basis"

Surya Pharmaceutical Limited has informed the Exchange that an Extraordinary General Meeting of the Members of the Company will be held on January 24, 2005, to transact the following business as special business:1)Increase the Authorised Share Capital of the Company . 2)To issue Zero Coupon Share Warrants convertible into equity shares.The details of the Notice of the EGM shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Surya Pharmaceutical Limited has informed the Exchange that the company convened a meeting of the BODs on December 23,2004.The said meeting was adjourned to be held on December 24,2004.The following decisions were taken at the aforesaid meeting:1)Subject to the approval of shareholders, the company has resolved to increase the authorised capital of the company from Rs.11 Crores, divided into 1,10,00,000 Equity Shares of Rs.10.00 each, to Rs.15 Crores, divided into 1,50,00,000 Equity Shares of Rs.10.00 each.2)Subject to the approval of the shareholders, the company has resolved to amend the Mem

Surya Pharmaceutical Limited has informed the Exchange that the BoD's of the company in their meeting held on September 29, 2004, have decided to mobilize the funds through Fixed Deposits.